Enterprise Europe Network (Profile: TRES20200420001)
The Spanish biotech company is expert in the development of tools for the early diagnosis of colon cancer based on minimally invasive approaches. They have a molecular signature based on some proteins and micro RNA (miRNA) biomarkers and look for partners for manufacturing kits and raw materials (reagents) for the analysis of these biomarkers. Technical and commercial agreement are also interested.
The organization is a Spanish biotechnological company with wide expertise in the diagnosis of cancer. Its main activity is the development of different in vitro diagnosis test (IVD). One of its products has been validated in a large prospective clinical study. Next step is manufacturing and commercialization of the diagnosis test.
The test is based on the determination of molecular biomarkers (combination of miRNAs and proteins in a predictive algorithm) which have been already validated by conventional ELISA/CLIA (enzyme-linked immune sorbent assay / chemi-luminescent immuno assay) and qPCR (quantitative polymerase chain reaction) in some clinical trials.
We are looking for partners for manufacturing kits, raw reagents for the analysis of miRNAs and proteins.
The cooperation type can be:
- A manufacturing agreement to participate in the manufacturing of the kits, in particular, in the production of the reagents and proteins.
- A commercialization agreement, to participate in the process of commercialization of the diagnosis kits and distribution in the markets. The partner seek shall have experienced in the diagnosis of cancer markets.
- A technical cooperation agreement to participate in the production of the reagents to analyze miRNA and proteins and scale-up. The partner seek shall have experience and abilities for the production of these reagents and scale-up processes.
For more information please contact Enterprise Europe Network Latvia.